Home > > > > > Report Detail

Telmisartan - Global Market Insights and Sales Trends 2024

Publisher Name :
Date: 21-Dec-2023
No. of pages: 107
Inquire Before Buying

The global Telmisartan market size is expected to reach US$ 3631.3 million by 2029, growing at a CAGR of 3.4% from 2023 to 2029. The market is mainly driven by the significant applications of Telmisartan in various end use industries. The expanding demands from the Hospital, Clinic and Others,, are propelling Telmisartan market. Injection, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Freeze-Dried Powder segment is estimated at % CAGR for the next seven-year period.

Asia Pacific shows high growth potential for Telmisartan market, driven by demand from China, the second largest economy with some signs of stabilising, the Telmisartan market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.

Report Objectives

This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking By Company; 3) comprehensive presentation of the global market for Telmisartan, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.

Key Features of The Study:

This report provides in-depth analysis of the global Telmisartan market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.

This report profiles key players in the global Telmisartan market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Telmisartan sales data, market share and ranking.

This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.

This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.

Key companies of Telmisartan covered in this report include Pfizer, Teva, Boehringer Ingelheim, Novartis, Mylan, Reddy's Laboratories (UK), Hema Pharmaceuticals Pvt, Bayer and GSK, etc.

The global Telmisartan market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.

Market Segmentation

Company Profiles:

- Pfizer

- Teva

- Boehringer Ingelheim

- Novartis

- Mylan

- Reddy's Laboratories (UK)

- Hema Pharmaceuticals Pvt

- Bayer

- GSK

- Astellas Pharma Inc

- Nippon Boehringer Ingelheim

- Abbott

- Takeda

- Beijing Wansheng Pharmaceutical

Global Telmisartan market, by region:

- North America (U.S., Canada, Mexico)

- Europe (Germany, France, UK, Italy, etc.)

- Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)

- South America (Brazil, etc.)

- Middle East and Africa (Turkey, GCC Countries, Africa, etc.)

Global Telmisartan market, Segment by Type:

- Injection

- Freeze-Dried Powder

Global Telmisartan market, by Application

- Hospital

- Clinic

- Others

Core Chapters

Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter Two: Detailed analysis of Telmisartan manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter Three: Sales, revenue of Telmisartan in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter Twelve: Analysis of sales channel, distributors and customers.

Chapter Thirteen: Research Findings and Conclusion.

Telmisartan - Global Market Insights and Sales Trends 2024

Table of Contents
1 Telmisartan Market Overview
1.1 Telmisartan Product Overview
1.2 Telmisartan Market Segment by Type
1.2.1 Injection
1.2.2 Freeze-Dried Powder
1.3 Global Telmisartan Market Size by Type
1.3.1 Global Telmisartan Market Size Overview by Type (2018-2029)
1.3.2 Global Telmisartan Historic Market Size Review by Type (2018-2023)
1.3.3 Global Telmisartan Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Telmisartan Sales Breakdown by Type (2018-2023)
1.4.2 Europe Telmisartan Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Telmisartan Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Telmisartan Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Telmisartan Sales Breakdown by Type (2018-2023)
2 Global Telmisartan Market Competition by Company
2.1 Global Top Players by Telmisartan Sales (2018-2023)
2.2 Global Top Players by Telmisartan Revenue (2018-2023)
2.3 Global Top Players by Telmisartan Price (2018-2023)
2.4 Global Top Manufacturers Telmisartan Manufacturing Base Distribution, Sales Area, Product Type
2.5 Telmisartan Market Competitive Situation and Trends
2.5.1 Telmisartan Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Telmisartan Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Telmisartan as of 2022)
2.7 Date of Key Manufacturers Enter into Telmisartan Market
2.8 Key Manufacturers Telmisartan Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Telmisartan Status and Outlook by Region
3.1 Global Telmisartan Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Telmisartan Historic Market Size by Region
3.2.1 Global Telmisartan Sales in Volume by Region (2018-2023)
3.2.2 Global Telmisartan Sales in Value by Region (2018-2023)
3.2.3 Global Telmisartan Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Telmisartan Forecasted Market Size by Region
3.3.1 Global Telmisartan Sales in Volume by Region (2024-2029)
3.3.2 Global Telmisartan Sales in Value by Region (2024-2029)
3.3.3 Global Telmisartan Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Telmisartan by Application
4.1 Telmisartan Market Segment by Application
4.1.1 Hospital
4.1.2 Clinic
4.1.3 Others
4.2 Global Telmisartan Market Size by Application
4.2.1 Global Telmisartan Market Size Overview by Application (2018-2029)
4.2.2 Global Telmisartan Historic Market Size Review by Application (2018-2023)
4.2.3 Global Telmisartan Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Telmisartan Sales Breakdown by Application (2018-2023)
4.3.2 Europe Telmisartan Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Telmisartan Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Telmisartan Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Telmisartan Sales Breakdown by Application (2018-2023)
5 North America Telmisartan by Country
5.1 North America Telmisartan Historic Market Size by Country
5.1.1 North America Telmisartan Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Telmisartan Sales in Volume by Country (2018-2023)
5.1.3 North America Telmisartan Sales in Value by Country (2018-2023)
5.2 North America Telmisartan Forecasted Market Size by Country
5.2.1 North America Telmisartan Sales in Volume by Country (2024-2029)
5.2.2 North America Telmisartan Sales in Value by Country (2024-2029)
6 Europe Telmisartan by Country
6.1 Europe Telmisartan Historic Market Size by Country
6.1.1 Europe Telmisartan Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Telmisartan Sales in Volume by Country (2018-2023)
6.1.3 Europe Telmisartan Sales in Value by Country (2018-2023)
6.2 Europe Telmisartan Forecasted Market Size by Country
6.2.1 Europe Telmisartan Sales in Volume by Country (2024-2029)
6.2.2 Europe Telmisartan Sales in Value by Country (2024-2029)
7 Asia-Pacific Telmisartan by Region
7.1 Asia-Pacific Telmisartan Historic Market Size by Region
7.1.1 Asia-Pacific Telmisartan Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Telmisartan Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Telmisartan Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Telmisartan Forecasted Market Size by Region
7.2.1 Asia-Pacific Telmisartan Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Telmisartan Sales in Value by Region (2024-2029)
8 Latin America Telmisartan by Country
8.1 Latin America Telmisartan Historic Market Size by Country
8.1.1 Latin America Telmisartan Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Telmisartan Sales in Volume by Country (2018-2023)
8.1.3 Latin America Telmisartan Sales in Value by Country (2018-2023)
8.2 Latin America Telmisartan Forecasted Market Size by Country
8.2.1 Latin America Telmisartan Sales in Volume by Country (2024-2029)
8.2.2 Latin America Telmisartan Sales in Value by Country (2024-2029)
9 Middle East and Africa Telmisartan by Country
9.1 Middle East and Africa Telmisartan Historic Market Size by Country
9.1.1 Middle East and Africa Telmisartan Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Telmisartan Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Telmisartan Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Telmisartan Forecasted Market Size by Country
9.2.1 Middle East and Africa Telmisartan Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Telmisartan Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Pfizer
10.1.1 Pfizer Company Information
10.1.2 Pfizer Introduction and Business Overview
10.1.3 Pfizer Telmisartan Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Pfizer Telmisartan Products Offered
10.1.5 Pfizer Recent Development
10.2 Teva
10.2.1 Teva Company Information
10.2.2 Teva Introduction and Business Overview
10.2.3 Teva Telmisartan Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Teva Telmisartan Products Offered
10.2.5 Teva Recent Development
10.3 Boehringer Ingelheim
10.3.1 Boehringer Ingelheim Company Information
10.3.2 Boehringer Ingelheim Introduction and Business Overview
10.3.3 Boehringer Ingelheim Telmisartan Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Boehringer Ingelheim Telmisartan Products Offered
10.3.5 Boehringer Ingelheim Recent Development
10.4 Novartis
10.4.1 Novartis Company Information
10.4.2 Novartis Introduction and Business Overview
10.4.3 Novartis Telmisartan Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Novartis Telmisartan Products Offered
10.4.5 Novartis Recent Development
10.5 Mylan
10.5.1 Mylan Company Information
10.5.2 Mylan Introduction and Business Overview
10.5.3 Mylan Telmisartan Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Mylan Telmisartan Products Offered
10.5.5 Mylan Recent Development
10.6 Reddy's Laboratories (UK)
10.6.1 Reddy's Laboratories (UK) Company Information
10.6.2 Reddy's Laboratories (UK) Introduction and Business Overview
10.6.3 Reddy's Laboratories (UK) Telmisartan Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Reddy's Laboratories (UK) Telmisartan Products Offered
10.6.5 Reddy's Laboratories (UK) Recent Development
10.7 Hema Pharmaceuticals Pvt
10.7.1 Hema Pharmaceuticals Pvt Company Information
10.7.2 Hema Pharmaceuticals Pvt Introduction and Business Overview
10.7.3 Hema Pharmaceuticals Pvt Telmisartan Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Hema Pharmaceuticals Pvt Telmisartan Products Offered
10.7.5 Hema Pharmaceuticals Pvt Recent Development
10.8 Bayer
10.8.1 Bayer Company Information
10.8.2 Bayer Introduction and Business Overview
10.8.3 Bayer Telmisartan Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Bayer Telmisartan Products Offered
10.8.5 Bayer Recent Development
10.9 GSK
10.9.1 GSK Company Information
10.9.2 GSK Introduction and Business Overview
10.9.3 GSK Telmisartan Sales, Revenue and Gross Margin (2018-2023)
10.9.4 GSK Telmisartan Products Offered
10.9.5 GSK Recent Development
10.10 Astellas Pharma Inc
10.10.1 Astellas Pharma Inc Company Information
10.10.2 Astellas Pharma Inc Introduction and Business Overview
10.10.3 Astellas Pharma Inc Telmisartan Sales, Revenue and Gross Margin (2018-2023)
10.10.4 Astellas Pharma Inc Telmisartan Products Offered
10.10.5 Astellas Pharma Inc Recent Development
10.11 Nippon Boehringer Ingelheim
10.11.1 Nippon Boehringer Ingelheim Company Information
10.11.2 Nippon Boehringer Ingelheim Introduction and Business Overview
10.11.3 Nippon Boehringer Ingelheim Telmisartan Sales, Revenue and Gross Margin (2018-2023)
10.11.4 Nippon Boehringer Ingelheim Telmisartan Products Offered
10.11.5 Nippon Boehringer Ingelheim Recent Development
10.12 Abbott
10.12.1 Abbott Company Information
10.12.2 Abbott Introduction and Business Overview
10.12.3 Abbott Telmisartan Sales, Revenue and Gross Margin (2018-2023)
10.12.4 Abbott Telmisartan Products Offered
10.12.5 Abbott Recent Development
10.13 Takeda
10.13.1 Takeda Company Information
10.13.2 Takeda Introduction and Business Overview
10.13.3 Takeda Telmisartan Sales, Revenue and Gross Margin (2018-2023)
10.13.4 Takeda Telmisartan Products Offered
10.13.5 Takeda Recent Development
10.14 Beijing Wansheng Pharmaceutical
10.14.1 Beijing Wansheng Pharmaceutical Company Information
10.14.2 Beijing Wansheng Pharmaceutical Introduction and Business Overview
10.14.3 Beijing Wansheng Pharmaceutical Telmisartan Sales, Revenue and Gross Margin (2018-2023)
10.14.4 Beijing Wansheng Pharmaceutical Telmisartan Products Offered
10.14.5 Beijing Wansheng Pharmaceutical Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Telmisartan Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Telmisartan Industrial Chain Analysis
11.4 Telmisartan Market Dynamics
11.4.1 Telmisartan Industry Trends
11.4.2 Telmisartan Market Drivers
11.4.3 Telmisartan Market Challenges
11.4.4 Telmisartan Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Telmisartan Distributors
12.3 Telmisartan Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
List of Tables
Table 1. Major Company of Injection
Table 2. Major Company of Freeze-Dried Powder
Table 3. Global Telmisartan Sales by Type 2018 VS 2022 VS 2029 (US$ Million)
Table 4. Global Telmisartan Sales by Type (2018-2023) & (MT)
Table 5. Global Telmisartan Sales Market Share in Volume by Type (2018-2023)
Table 6. Global Telmisartan Sales by Type (2018-2023) & (US& Million)
Table 7. Global Telmisartan Market Share in Value by Type (2018-2023)
Table 8. Global Telmisartan Price by Type (2018-2023) & (USD/Kg)
Table 9. Global Telmisartan Sales by Type (2024-2029) & (MT)
Table 10. Global Telmisartan Sales Market Share in Volume by Type (2024-2029)
Table 11. Global Telmisartan Sales by Type (2024-2029) & (US$ Million)
Table 12. Global Telmisartan Sales Market Share in Value by Type (2024-2029)
Table 13. Global Telmisartan Price by Type (2024-2029) & (USD/Kg)
Table 14. North America Telmisartan Sales by Type (2018-2023) & (MT)
Table 15. North America Telmisartan Sales by Type (2018-2023) & (US$ Million)
Table 16. Europe Telmisartan Sales (MT) by Type (2018-2023)
Table 17. Europe Telmisartan Sales by Type (2018-2023) & (US$ Million)
Table 18. Asia-Pacific Telmisartan Sales (MT) by Type (2018-2023)
Table 19. Asia-Pacific Telmisartan Sales by Type (2018-2023) & (US$ Million)
Table 20. Latin America Telmisartan Sales (MT) by Type (2018-2023)
Table 21. Latin America Telmisartan Sales by Type (2018-2023) & (US$ Million)
Table 22. Middle East and Africa Telmisartan Sales (MT) by Type (2018-2023)
Table 23. Middle East and Africa Telmisartan Sales by Type (2018-2023) & (US$ Million)
Table 24. Global Telmisartan Sales by Company (2018-2023) & (MT)
Table 25. Global Telmisartan Sales Share by Company (2018-2023)
Table 26. Global Telmisartan Revenue by Company (2018-2023) & (US$ Million)
Table 27. Global Telmisartan Revenue Share by Company (2018-2023)
Table 28. Global Market Telmisartan Price by Company (2018-2023) & (USD/Kg)
Table 29. Global Telmisartan Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 30. Global Telmisartan Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 31. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Telmisartan as of 2022)
Table 32. Date of Key Manufacturers Enter into Telmisartan Market
Table 33. Key Manufacturers Telmisartan Product Type
Table 34. Mergers & Acquisitions, Expansion Plans
Table 35. Global Telmisartan Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2029
Table 36. Global Telmisartan Sales by Region (2018-2023) & (MT)
Table 37. Global Telmisartan Sales Market Share in Volume by Region (2018-2023)
Table 38. Global Telmisartan Sales by Region (2018-2023) & (US$ Million)
Table 39. Global Telmisartan Sales Market Share in Value by Region (2018-2023)
Table 40. Global Telmisartan Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2023)
Table 41. Global Telmisartan Sales by Region (2024-2029) & (MT)
Table 42. Global Telmisartan Sales Market Share in Volume by Region (2024-2029)
Table 43. Global Telmisartan Sales by Region (2024-2029) & (US$ Million)
Table 44. Global Telmisartan Sales Market Share in Value by Region (2024-2029)
Table 45. Global Telmisartan Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2024-2029)
Table 46. Global Telmisartan Sales by Application: 2018 VS 2022 VS 2029 (US$ Million)
Table 47. Global Telmisartan Sales by Application (2018-2023) & (MT)
Table 48. Global Telmisartan Sales Market Share in Volume by Application (2018-2023)
Table 49. Global Telmisartan Sales by Application (2018-2023) & (US$ Million)
Table 50. Global Telmisartan Sales Market Share in Value by Application (2018-2023)
Table 51. Global Telmisartan Price by Application (2018-2023) & (USD/Kg)
Table 52. Global Telmisartan Sales by Application (2024-2029) & (MT)
Table 53. Global Telmisartan Sales Market Share in Volume by Application (2024-2029)
Table 54. Global Telmisartan Sales by Application (2024-2029) & (US$ Million)
Table 55. Global Telmisartan Sales Market Share in Value by Application (2024-2029)
Table 56. Global Telmisartan Price by Application (2024-2029) & (USD/Kg)
Table 57. North America Telmisartan Sales by Application (2018-2023) (MT)
Table 58. North America Telmisartan Sales by Application (2018-2023) & (US$ Million)
Table 59. Europe Telmisartan Sales by Application (2018-2023) (MT)
Table 60. Europe Telmisartan Sales by Application (2018-2023) & (US$ Million)
Table 61. Asia-Pacific Telmisartan Sales by Application (2018-2023) (MT)
Table 62. Asia-Pacific Telmisartan Sales by Application (2018-2023) & (US$ Million)
Table 63. Latin America Telmisartan Sales by Application (2018-2023) (MT)
Table 64. Latin America Telmisartan Sales by Application (2018-2023) & (US$ Million)
Table 65. Middle East and Africa Telmisartan Sales by Application (2018-2023) (MT)
Table 66. Middle East and Africa Telmisartan Sales by Application (2018-2023) & (US$ Million)
Table 67. North America Telmisartan Sales by Country (2018-2023) & (MT)
Table 68. North America Telmisartan Sales Market Share in Volume by Country (2018-2023)
Table 69. North America Telmisartan Sales by Country (2018-2023) & (US$ Million)
Table 70. North America Telmisartan Sales Market Share in Value by Country (2018-2023)
Table 71. North America Telmisartan Sales by Country (2024-2029) & (MT)
Table 72. North America Telmisartan Sales Market Share in Volume by Country (2024-2029)
Table 73. North America Telmisartan Sales by Country (2024-2029) & (US$ Million)
Table 74. North America Telmisartan Sales Market Share in Value by Country (2024-2029)
Table 75. Europe Telmisartan Sales by Country (2018-2023) & (MT)
Table 76. Europe Telmisartan Sales Market Share in Volume by Country (2018-2023)
Table 77. Europe Telmisartan Sales by Country (2018-2023) & (US$ Million)
Table 78. Europe Telmisartan Sales Market Share in Value by Country (2018-2023)
Table 79. Europe Telmisartan Sales by Country (2024-2029) & (MT)
Table 80. Europe Telmisartan Sales Market Share in Volume by Country (2024-2029)
Table 81. Europe Telmisartan Sales by Country (2024-2029) & (US$ Million)
Table 82. Europe Telmisartan Sales Market Share in Value by Country (2024-2029)
Table 83. Asia-Pacific Telmisartan Sales by Region (2018-2023) & (MT)
Table 84. Asia-Pacific Telmisartan Sales Market Share in Volume by Region (2018-2023)
Table 85. Asia-Pacific Telmisartan Sales by Region (2018-2023) & (US$ Million)
Table 86. Asia-Pacific Telmisartan Sales Market Share in Value by Region (2018-2023)
Table 87. Asia-Pacific Telmisartan Sales by Region (2024-2029) & (MT)
Table 88. Asia-Pacific Telmisartan Sales Market Share in Volume by Region (2024-2029)
Table 89. Asia-Pacific Telmisartan Sales by Region (2024-2029) & (US$ Million)
Table 90. Asia-Pacific Telmisartan Sales Market Share in Value by Region (2024-2029)
Table 91. Latin America Telmisartan Sales by Country (2018-2023) & (MT)
Table 92. Latin America Telmisartan Sales Market Share in Volume by Country (2018-2023)
Table 93. Latin America Telmisartan Sales by Country (2018-2023) & (US$ Million)
Table 94. Latin America Telmisartan Sales Market Share in Value by Country (2018-2023)
Table 95. Latin America Telmisartan Sales by Country (2024-2029) & (MT)
Table 96. Latin America Telmisartan Sales Market Share in Volume by Country (2024-2029)
Table 97. Latin America Telmisartan Sales by Country (2024-2029) & (US$ Million)
Table 98. Latin America Telmisartan Sales Market Share in Value by Country (2024-2029)
Table 99. Middle East and Africa Telmisartan Sales by Country (2018-2023) & (MT)
Table 100. Middle East and Africa Telmisartan Sales Market Share in Volume by Country (2018-2023)
Table 101. Middle East and Africa Telmisartan Sales by Country (2018-2023) & (US$ Million)
Table 102. Middle East and Africa Telmisartan Sales Market Share in Value by Country (2018-2023)
Table 103. Middle East and Africa Telmisartan Sales by Country (2024-2029) & (MT)
Table 104. Middle East and Africa Telmisartan Sales Market Share in Volume by Country (2024-2029)
Table 105. Middle East and Africa Telmisartan Sales by Country (2024-2029) & (US$ Million)
Table 106. Middle East and Africa Telmisartan Sales Market Share in Value by Country (2024-2029)
Table 107. Pfizer Company Information
Table 108. Pfizer Introduction and Business Overview
Table 109. Pfizer Telmisartan Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2018-2023)
Table 110. Pfizer Telmisartan Product
Table 111. Pfizer Recent Development
Table 112. Teva Company Information
Table 113. Teva Introduction and Business Overview
Table 114. Teva Telmisartan Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2018-2023)
Table 115. Teva Telmisartan Product
Table 116. Teva Recent Development
Table 117. Boehringer Ingelheim Company Information
Table 118. Boehringer Ingelheim Introduction and Business Overview
Table 119. Boehringer Ingelheim Telmisartan Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2018-2023)
Table 120. Boehringer Ingelheim Telmisartan Product
Table 121. Boehringer Ingelheim Recent Development
Table 122. Novartis Company Information
Table 123. Novartis Introduction and Business Overview
Table 124. Novartis Telmisartan Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2018-2023)
Table 125. Novartis Telmisartan Product
Table 126. Novartis Recent Development
Table 127. Mylan Company Information
Table 128. Mylan Introduction and Business Overview
Table 129. Mylan Telmisartan Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2018-2023)
Table 130. Mylan Telmisartan Product
Table 131. Mylan Recent Development
Table 132. Reddy's Laboratories (UK) Company Information
Table 133. Reddy's Laboratories (UK) Introduction and Business Overview
Table 134. Reddy's Laboratories (UK) Telmisartan Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2018-2023)
Table 135. Reddy's Laboratories (UK) Telmisartan Product
Table 136. Reddy's Laboratories (UK) Recent Development
Table 137. Hema Pharmaceuticals Pvt Company Information
Table 138. Hema Pharmaceuticals Pvt Introduction and Business Overview
Table 139. Hema Pharmaceuticals Pvt Telmisartan Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2018-2023)
Table 140. Hema Pharmaceuticals Pvt Telmisartan Product
Table 141. Hema Pharmaceuticals Pvt Recent Development
Table 142. Bayer Company Information
Table 143. Bayer Introduction and Business Overview
Table 144. Bayer Telmisartan Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2018-2023)
Table 145. Bayer Telmisartan Product
Table 146. Bayer Recent Development
Table 147. GSK Company Information
Table 148. GSK Introduction and Business Overview
Table 149. GSK Telmisartan Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2018-2023)
Table 150. GSK Telmisartan Product
Table 151. GSK Recent Development
Table 152. Astellas Pharma Inc Company Information
Table 153. Astellas Pharma Inc Introduction and Business Overview
Table 154. Astellas Pharma Inc Telmisartan Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2018-2023)
Table 155. Astellas Pharma Inc Telmisartan Product
Table 156. Astellas Pharma Inc Recent Development
Table 157. Nippon Boehringer Ingelheim Company Information
Table 158. Nippon Boehringer Ingelheim Introduction and Business Overview
Table 159. Nippon Boehringer Ingelheim Telmisartan Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2018-2023)
Table 160. Nippon Boehringer Ingelheim Telmisartan Product
Table 161. Nippon Boehringer Ingelheim Recent Development
Table 162. Abbott Company Information
Table 163. Abbott Introduction and Business Overview
Table 164. Abbott Telmisartan Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2018-2023)
Table 165. Abbott Telmisartan Product
Table 166. Abbott Recent Development
Table 167. Takeda Company Information
Table 168. Takeda Introduction and Business Overview
Table 169. Takeda Telmisartan Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2018-2023)
Table 170. Takeda Telmisartan Product
Table 171. Takeda Recent Development
Table 172. Beijing Wansheng Pharmaceutical Company Information
Table 173. Beijing Wansheng Pharmaceutical Introduction and Business Overview
Table 174. Beijing Wansheng Pharmaceutical Telmisartan Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2018-2023)
Table 175. Beijing Wansheng Pharmaceutical Telmisartan Product
Table 176. Beijing Wansheng Pharmaceutical Recent Development
Table 177. Key Raw Materials Lists
Table 178. Raw Materials Key Suppliers Lists
Table 179. Telmisartan Market Trends
Table 180. Telmisartan Market Drivers
Table 181. Telmisartan Market Challenges
Table 182. Telmisartan Market Restraints
Table 183. Telmisartan Distributors List
Table 184. Telmisartan Downstream Customers
Table 185. Research Programs/Design for This Report
Table 186. Key Data Information from Secondary Sources
Table 187. Key Data Information from Primary Sources
List of Figures
Figure 1. Telmisartan Product Picture
Figure 2. Global Telmisartan Market Size, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Telmisartan Market Size Status and Outlook (2018-2029) & (US$ Million)
Figure 4. Global Telmisartan Sales Status and Outlook (2018-2029) & (MT)
Figure 5. Product Picture of Injection
Figure 6. Global Injection Sales YoY Growth (2018-2029) & (MT)
Figure 7. Product Picture of Freeze-Dried Powder
Figure 8. Global Freeze-Dried Powder Sales YoY Growth (2018-2029) & (MT)
Figure 9. Global Telmisartan Sales by Type (2018-2029) & (US$ Million)
Figure 10. Global Telmisartan Sales Market Share by Type in 2022 & 2029
Figure 11. North America Telmisartan Sales Market Share in Volume by Type in 2022
Figure 12. North America Telmisartan Sales Market Share in Value by Type in 2022
Figure 13. Europe Telmisartan Sales Market Share in Volume by Type in 2022
Figure 14. Europe Telmisartan Sales Market Share in Value by Type in 2022
Figure 15. Asia-Pacific Telmisartan Sales Market Share in Volume by Type in 2022
Figure 16. Asia-Pacific Telmisartan Sales Market Share in Value by Type in 2022
Figure 17. Latin America Telmisartan Sales Market Share in Volume by Type in 2022
Figure 18. Latin America Telmisartan Sales Market Share in Value by Type in 2022
Figure 19. Middle East and Africa Telmisartan Sales Market Share in Volume by Type in 2022
Figure 20. Middle East and Africa Telmisartan Sales Market Share in Value by Type in 2022
Figure 21. The 5 and 10 Largest Manufacturers in the World: Market Share by Telmisartan Sales in 2022
Figure 22. The 5 and 10 Largest Manufacturers in the World: Market Share by Telmisartan Revenue in 2022
Figure 23. Telmisartan Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 24. Product Picture of Hospital
Figure 25. Global Hospital Sales YoY Growth (2018-2029) & (MT)
Figure 26. Product Picture of Clinic
Figure 27. Global Clinic Sales YoY Growth (2018-2029) & (MT)
Figure 28. Product Picture of Others
Figure 29. Global Others Sales YoY Growth (2018-2029) & (MT)
Figure 30. Global Telmisartan Sales by Application (2018-2029) & (US$ Million)
Figure 31. Global Telmisartan Sales Market Share by Application in 2022 & 2029
Figure 32. North America Telmisartan Sales Market Share in Volume by Application in 2022
Figure 33. North America Telmisartan Sales Market Share in Value by Application in 2022
Figure 34. Europe Telmisartan Sales Market Share in Volume by Application in 2022
Figure 35. Europe Telmisartan Sales Market Share in Value by Application in 2022
Figure 36. Asia-Pacific Telmisartan Sales Market Share in Volume by Application in 2022
Figure 37. Asia-Pacific Telmisartan Sales Market Share in Value by Application in 2022
Figure 38. Latin America Telmisartan Sales Market Share in Volume by Application in 2022
Figure 39. Latin America Telmisartan Sales Market Share in Value by Application in 2022
Figure 40. Middle East and Africa Telmisartan Sales Market Share in Value by Application in 2022
Figure 41. Key Raw Materials Price
Figure 42. Telmisartan Manufacturing Cost Structure
Figure 43. Telmisartan Industrial Chain Analysis
Figure 44. Channels of Distribution
Figure 45. Distributors Profiles
Figure 46. Bottom-up and Top-down Approaches for This Report
Figure 47. Data Triangulation
Figure 48. Key Executives Interviewed
  • Global Pulmonary Arterial Hypertension (Pah) Medicine Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 04-Jan-2024        Price: US 3380 Onwards        Pages: 103
    Market Overview of Global Pulmonary Arterial Hypertension (Pah) Medicine market: According to our latest research, the global Pulmonary Arterial Hypertension (Pah) Medicine market looks promising in the next 5 years. As of 2022, the global Pulmonary Arterial Hypertension (Pah) Medicine market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to ......
  • Global Nifedipine Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 04-Jan-2024        Price: US 3380 Onwards        Pages: 102
    Market Overview of Global Nifedipine market: According to our latest research, the global Nifedipine market looks promising in the next 5 years. As of 2022, the global Nifedipine market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Nifedipine market, with a systematical de......
  • Global Amlodipine Besylate Market Research Report 2024
    Published: 04-Jan-2024        Price: US 2900 Onwards        Pages: 115
    The Amlodipine Besylate market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Amlodipine Besylate market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profil......
  • Pulmonary Arterial Hypertension (PAH) Drugs - Global Market Insights and Sales Trends 2024
    Published: 25-Dec-2023        Price: US 3350 Onwards        Pages: 112
    The global Pulmonary Arterial Hypertension (PAH) Drugs market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Pulmonary Arterial Hypertension (PAH) Drugs in various end use industries. The expanding demands from the Hospitals, Clinics and Other,, are propelling Pulmonary Arterial Hypertension (PAH) Drugs market. Inhalation, one of the segments analysed in this report, is projected to record % ......
  • Captopril API - Global Market Insights and Sales Trends 2024
    Published: 25-Dec-2023        Price: US 3350 Onwards        Pages: 100
    The global Captopril API market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Captopril API in various end use industries. The expanding demands from the Captopril Tablet, Compound Captopril Tablet and Captopril Injection,, are propelling Captopril API market. 98% Captopril API, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the......
  • Telmisartan - Global Market Insights and Sales Trends 2024
    Published: 21-Dec-2023        Price: US 3350 Onwards        Pages: 107
    The global Telmisartan market size is expected to reach US$ 3631.3 million by 2029, growing at a CAGR of 3.4% from 2023 to 2029. The market is mainly driven by the significant applications of Telmisartan in various end use industries. The expanding demands from the Hospital, Clinic and Others,, are propelling Telmisartan market. Injection, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Freeze-Dried......
  • Global Ambrisentan Professional Survey Report 2023, Forecast to 2028
    Published: 20-Dec-2023        Price: US 3280 Onwards        Pages: 106
    Ambrisentan is a drug indicated for use in the treatment of pulmonary hypertension. The peptide endothelin constricts muscles in blood vessels, increasing blood pressure. Ambrisentan, which relaxes those muscles, is an endothelin receptor antagonist, and is selective for the type A endothelin receptor. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million US......
  • Global Ambrisentan Market Research Report 2023, Forecast to 2028
    Published: 20-Dec-2023        Price: US 2680 Onwards        Pages: 132
    Ambrisentan is a drug indicated for use in the treatment of pulmonary hypertension. The peptide endothelin constricts muscles in blood vessels, increasing blood pressure. Ambrisentan, which relaxes those muscles, is an endothelin receptor antagonist, and is selective for the type A endothelin receptor. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million US......
  • Global Amlodipine Besylate Professional Survey Report 2023, Forecast to 2028
    Published: 20-Dec-2023        Price: US 3280 Onwards        Pages: 133
    Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technological advancements, new product launches, and market capital flows are compared across scenarios to demonstrate their impact over the forecast period. D......
    • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs